Regulatory Updates
Aug 30, 2026•1 min read
Korea Sets 0.018% Basic Burden Rate for 2026 Drug Adverse Reaction Compensation Fund
The Korea Pharmaceutical Safety Management Agency announced a 0.018% basic burden rate for the 2026 drug adverse reaction compensation fund, applicable to the Jan and July assessments.
Regulatory Updates
Aug 30, 2026•1 min read
KRPIA Welcomes First Joint Drug Review via EMA's OPEN Program
KRPIA praised MFDS for completing the first joint pharmaceutical review with overseas regulators through EMA's OPEN program, marking a milestone in Korea‑EU collaboration.
1
Regulatory Updates
Aug 30, 2026•1 min read
World’s First Oral BTK Inhibitor Approved for Chronic Spontaneous Urticaria in Korea
Labsi’s 25 mg twice‑daily oral BTK inhibitor received Korean approval as the first oral therapy for chronic spontaneous urticaria, expanding options beyond injectable second‑line treatments.
Regulatory Updates
Aug 29, 2026•1 min read
South Korea Introduces New ‘Pancreas Disability’ Category Effective July 1
From July 1, South Korea will recognize severe pancreatic dysfunction as a new disability category, benefiting type 1 diabetes patients. A ceremony will mark the first Pancreas Disability Day.
Regulatory Updates
Aug 26, 2026•1 min read
South Korean Government Initiates Wide‑Scale Probe into Illegal Medical Practices Targeting Cancer Patients
The Ministry of Health and Welfare’s Abnormal and Fake Treatment Investigation Unit announced on the 18th that it will immediately begin on‑site investigations of suspected illegal practices such as patient recruitment, pay‑back schemes, and high‑cost non‑covered treatments aimed at cancer patients.
Regulatory Updates
Aug 24, 2026•1 min read
Korean Pharmacists Hold 273rd Relay Protest for Herbal Pharmacist Licensing Reform
The Korean Pharmaceutical Association and regional pharmacy societies held the 273rd relay protest in front of the Blue House, urging the government and parliament to amend the Pharmacy Act and define clear licensing for herbal pharmacists.
Regulatory Updates
Aug 24, 2026•1 min read
Korean Government Reaffirms Separate Payment Policy for Specimen Tests
Amid medical sector backlash, the Ministry of Health and Welfare reiterates its plan to implement separate payments for specimen testing and pursue spending efficiency measures.
Regulatory Updates
Aug 24, 2026•1 min read
South Korea proposes amendment to ban promotional sales by telemedicine platforms
A medical law amendment introduced by lawmaker Lee Hoon-gi aims to prohibit telemedicine intermediaries from selling drugs and conducting promotional activities, ensuring neutrality in drug distribution.